1) To identify chromosomal regions associated with the EoE-phenotype in a family with multiple affected family members. Subsequently these regions will be sequenced to detect causative gene(s).2) To describe the clinical characteristics of EoE-…
ID
Source
Brief title
Condition
- Gastrointestinal tract disorders congenital
- Gastrointestinal inflammatory conditions
- Allergic conditions
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The linkage to one or more chromosomal regions and identification of associated
gene(s) in the EoE family.
Secondary outcome
Clinical characteristics of EoE patients in this family.
Background summary
EoE is a rapidly increasing disorder which usually presents with dysphagia. The
pathophysiology remains largely unexplained. An allergic pathway is suggested
by the observation that a large proportion of EoE patients has an atopic
constitution and elementary diets have been shown to have a beneficial effect.
Familial clustering indicates that genetic factors play a role as well in the
pathophysiology. EoE shows a sibling risk ratio (*S) of approximately 80, which
is high compared to other atopic diseases such as asthma (*S about 2).
So far, only few Genome Wide Association Studies (GWAS) have been performed
aiming to identify loci associated with EoE. GWAS have shown associations with
CCL26 (encoding for eotaxin-3) in 14% of EoE patients, and with TGFB1, TSLP,
and FLG in smaller percentages of patients. No replication studies have yet
been performed to confirm these associations. No pathological mutations have
been described in EoE patients.
We reason that performing molecular analyses in a well-defined family with
multiple affected members with EoE may allow identification of genes associated
with EoE, especially if linkage and sequencing studies are combined.
Study objective
1) To identify chromosomal regions associated with the EoE-phenotype in a
family with multiple affected family members. Subsequently these regions will
be sequenced to detect causative gene(s).
2) To describe the clinical characteristics of EoE-patients within this family.
Study design
We will perform linkage analysis in one family with EoE-patients in multiple
generations. Suggestive chromosomal regions identified by linkage analysis will
be further investigated by Sanger sequencing or next generation sequencing,
depending on the number and the size of the identified regions.
Clinical information will be obtained from a questionnaire.
Study burden and risks
Peripheral blood drawing will be performed once and does not bring along any
mentionable risks
Filling out the questionnaire will take 20 minutes.
Meibergdreef 9
Amsterdam 1105 AZ
NL
Meibergdreef 9
Amsterdam 1105 AZ
NL
Listed location countries
Age
Inclusion criteria
- Adult family members fulfilling criteria for EoE
- Adult family members without EoE
- Written informed consent
Exclusion criteria
None
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL41358.018.12 |